Move from Amble to PlexusDx with coordinated timing, no prescription gap, and clear cost comparisons for semaglutide and tirzepatide. A licensed provider reviews every transfer.

Amble holds semaglutide at one rate across all doses but charges $40/month more when tirzepatide patients move from 2.5–5 mg to 7.5–15 mg. PlexusDx holds the same price at every dose for both medications.

Amble charges a first-month rate for compounded semaglutide and ongoing monthly fees for tirzepatide, all-inclusive with no membership fee. This breakdown compares Amble's cash-pay GLP-1 rates against PlexusDx across semaglutide and tirzepatide on a month-to-month basis and over 12 months.

Amble charges $289/month for tirzepatide starter doses and $329/month for higher doses. We break down how the two-tier pricing affects your first-year cost and show the like-for-like alternatives.

Amble charges a first-month semaglutide rate and standard tirzepatide pricing depending on dose, with no membership fee. We compare the all-in monthly and annual costs against PlexusDx's flat-rate structure.

Amble charges a first-month rate for semaglutide and tiered monthly pricing for tirzepatide; PlexusDx prices semaglutide at $189/month and tirzepatide flat at $289/month across all doses.

Amble quotes $289–$329/month for tirzepatide month-to-month, while AltRx advertises promotional rates through September 5, 2026, with no standard pricing documented—a material gap for long-term planning.